Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...

In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for ...

from the 2017 to 2020 National Health and Nutrition Examination Survey who would meet clinical trial inclusion criteria for antiobesity medications. The researchers found that tirzepatide and ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...

Clinical trials to continue the development of a liver ... without type 2 diabetes found that those who persisted with Tirzepatide for at least six months lost an average of 12.9% of their body ...

Additionally, researchers observed that the rate of continuation for continuing to use tirzepatide for 6 months ... about ...

Data were included from 4,823 individuals, aged 20 to 79 years, from the 2017 to 2020 National Health and Nutrition ...